Gemphire Therapeutics Inc. Business Finance Contracts & Agreements
73 Contracts & Agreements
- Equity Distribution Agreements (14 contracts)
- Investor Rights Agreements (2)
- Joinder Agreements (1)
- Loan Agreements (2)
- Modification Agreements (1)
- Note Agreements (1)
- Purchase Agreements (9)
- Registration Rights Agreements (6)
- Release Agreements (1)
- Shareholders Agreements (1)
- Stock Agreements (5)
- Underwriting Agreements (7)
- Waiver Agreements (1)
- Warrant Agreements (22)
Recent Contracts
Category
Company
Industry
Jur.
Filed
Gemphire Therapeutics Inc.
2025
Gemphire Therapeutics Inc.
NY
2025
Gemphire Therapeutics Inc.
NY
2025
Gemphire Therapeutics Inc.
DE
2025
Gemphire Therapeutics Inc.
DE
2025
Gemphire Therapeutics Inc.
2025
Gemphire Therapeutics Inc.
2024
Gemphire Therapeutics Inc.
NY
2024
Gemphire Therapeutics Inc.
NY
2024
Gemphire Therapeutics Inc.
2024
Gemphire Therapeutics Inc.
2024
Gemphire Therapeutics Inc.
2024
Gemphire Therapeutics Inc.
2024
Gemphire Therapeutics Inc.
2024
Gemphire Therapeutics Inc.
2023
Gemphire Therapeutics Inc.
2023
Gemphire Therapeutics Inc.
2023
Gemphire Therapeutics Inc.
DE
2022
Gemphire Therapeutics Inc.
DE
2022
Gemphire Therapeutics Inc.
2022
Gemphire Therapeutics Inc.
NY
2022
Series A Common Stock Purchase Warrant between NeuroBo Pharmaceuticals, Inc. and Dong-A ST Co., Ltd.
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
DE
2022
Gemphire Therapeutics Inc.
2022
Gemphire Therapeutics Inc.
2022
Gemphire Therapeutics Inc.
2022
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
DE
2022
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
DE
2022
Gemphire Therapeutics Inc.
2022
Gemphire Therapeutics Inc.
2022
Gemphire Therapeutics Inc.
NY
2022
Gemphire Therapeutics Inc.
DE
2021
Securities Purchase Agreement between NeuroBo Pharmaceuticals, Inc. and Purchasers (October 1, 2021)
Gemphire Therapeutics Inc.
NY
2021